Terms: = Breast cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Treatment
35 results:
1. Anthracycline-related cardiotoxicity in patients with breast cancer harboring mutational signature of homologous recombination deficiency (HRD).
Incorvaia L; Badalamenti G; Novo G; Gori S; Cortesi L; Brando C; Cinieri S; Curigliano G; Ricciardi GR; Toss A; Chiari R; Berardi R; Ballatore Z; Bono M; Bazan Russo TD; Gristina V; Galvano A; Damerino G; Blasi L; Bazan V; Russo A
ESMO Open; 2024 Jan; 9(1):102196. PubMed ID: 38118367
[TBL] [Abstract] [Full Text] [Related]
2. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
Mutat Res; 2023; 827():111831. PubMed ID: 37453313
[TBL] [Abstract] [Full Text] [Related]
3. Mismatch repair-deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of Lynch syndrome.
Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
[TBL] [Abstract] [Full Text] [Related]
4. Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facility.
Kawamura M; Shirota H; Niihori T; Komine K; Takahashi M; Takahashi S; Miyauchi E; Niizuma H; Kikuchi A; Tada H; Shimada M; Kawamorita N; Kanamori M; Sugiyama I; Tsubata M; Ichikawa H; Yasuda J; Furukawa T; Aoki Y; Ishioka C
J Hum Genet; 2023 Jun; 68(6):399-408. PubMed ID: 36804482
[TBL] [Abstract] [Full Text] [Related]
5. S6K1 phosphorylates Cdk1 and msh6 to regulate DNA repair.
Amar-Schwartz A; Ben Hur V; Jbara A; Cohen Y; Barnabas GD; Arbib E; Siegfried Z; Mashahreh B; Hassouna F; Shilo A; Abu-Odeh M; Berger M; Wiener R; Aqeilan R; Geiger T; Karni R
Elife; 2022 Oct; 11():. PubMed ID: 36189922
[TBL] [Abstract] [Full Text] [Related]
6. Pancreatic cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
[TBL] [Abstract] [Full Text] [Related]
7. 30 year experience of index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes.
Woodward ER; Green K; Burghel GJ; Bulman M; Clancy T; Lalloo F; Schlecht H; Wallace AJ; Evans DG
Eur J Hum Genet; 2022 Apr; 30(4):413-419. PubMed ID: 34866136
[TBL] [Abstract] [Full Text] [Related]
8. [Difference analysis of somatic mutations between deficient mismatch repair and proficient mismatch repair gene related with colorectal cancer].
Tang XJ; Yang MY; Zhu LZ; Xu D; Yuan Y
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1088-1093. PubMed ID: 34695900
[No Abstract] [Full Text] [Related]
9. Can evaluation of mismatch repair defect and TILs increase the number of triple-negative breast cancer patients eligible for immunotherapy?
Özcan D; Lade-Keller J; Tramm T
Pathol Res Pract; 2021 Oct; 226():153606. PubMed ID: 34530255
[TBL] [Abstract] [Full Text] [Related]
10. [Germline and Somatic Mutations in Archived breast cancer Specimens of Different Subtypes].
Abramov IS; Korneva YS; Shisterova OA; Ikonnikova AY; Emelyanova MA; Lisitsa TS; Krasnov GS; Nasedkina TV
Mol Biol (Mosk); 2021; 55(3):412-421. PubMed ID: 34097676
[TBL] [Abstract] [Full Text] [Related]
11. Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
Laish I; Friedman E; Levi-Reznick G; Kedar I; Katz L; Levi Z; Halpern N; Parnasa S; Abu-Shatya A; Half E; Goldberg Y
Breast Cancer Res Treat; 2021 Aug; 188(3):685-694. PubMed ID: 34086170
[TBL] [Abstract] [Full Text] [Related]
12. The contribution of Lynch syndrome to early onset malignancy in Ireland.
Talbot A; O'Donovan E; Berkley E; Nolan C; Clarke R; Gallagher D
BMC Cancer; 2021 May; 21(1):617. PubMed ID: 34039291
[TBL] [Abstract] [Full Text] [Related]
13. New germline mutations in BRCA1, ATM, MUTYH, and RAD51D genes in Tuvans early-onset breast cancer patients.
Gervas P; Molokov A; Ivanova A; Panferova Y; Kiselev A; Chernyshova A; Pisareva L; Choynzonov E; Cherdyntseva N
Exp Oncol; 2021 Mar; 43(1):52-55. PubMed ID: 33785725
[TBL] [Abstract] [Full Text] [Related]
14. Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With breast cancer or Ovarian cancer, 2012-2019.
Kurian AW; Ward KC; Abrahamse P; Bondarenko I; Hamilton AS; Deapen D; Morrow M; Berek JS; Hofer TP; Katz SJ
J Clin Oncol; 2021 May; 39(15):1631-1640. PubMed ID: 33560870
[TBL] [Abstract] [Full Text] [Related]
15. Hereditary Predisposition to Prostate cancer: From Genetics to Clinical Implications.
Brandão A; Paulo P; Teixeira MR
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708810
[TBL] [Abstract] [Full Text] [Related]
16. Mismatch repair gene pathogenic germline variants in a population-based cohort of breast cancer.
Nguyen-Dumont T; Steen JA; Winship I; Park DJ; Pope BJ; Hammet F; Mahmoodi M; Tsimiklis H; Theys D; Clendenning M; Giles GG; Hopper JL; Southey MC
Fam Cancer; 2020 Jul; 19(3):197-202. PubMed ID: 32060697
[TBL] [Abstract] [Full Text] [Related]
17. Mismatch repair protein loss in breast cancer: clinicopathological associations in a large British Columbia cohort.
Cheng AS; Leung SCY; Gao D; Burugu S; Anurag M; Ellis MJ; Nielsen TO
Breast Cancer Res Treat; 2020 Jan; 179(1):3-10. PubMed ID: 31522348
[TBL] [Abstract] [Full Text] [Related]
18. Germline TP53 and msh6 mutations implicated in sporadic triple-negative breast cancer (TNBC): a preliminary study.
Yi D; Xu L; Luo J; You X; Huang T; Zi Y; Li X; Wang R; Zhong Z; Tang X; Li A; Shi Y; Rao J; Zhang Y; Sang J
Hum Genomics; 2019 Jan; 13(1):4. PubMed ID: 30630526
[TBL] [Abstract] [Full Text] [Related]
19. Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report.
Gohda Y; Noguchi R; Horie T; Igari T; Nakamura H; Ohta Y; Yamaguchi K; Ikenoue T; Hatakeyama S; Yusa N; Furukawa Y; Yano H
BMC Med Genet; 2016 Dec; 17(1):94. PubMed ID: 27938333
[TBL] [Abstract] [Full Text] [Related]
20. The genetic prediction of risk for gynecologic cancers.
Randall LM; Pothuri B
Gynecol Oncol; 2016 Apr; 141(1):10-6. PubMed ID: 27016223
[TBL] [Abstract] [Full Text] [Related]
[Next]
